MET and neoplasm: In SNU‐1 cell line derived subcutaneous xenografts that do not overexpress c‐Met, there was no notable effect on tumour size by oxaliplatin, while single‐agent therapy with nab‐paclitaxel and foretinib decreased tumour size by 76% and 46%, respectively.